Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Published species reactivity||Human|
|Host / Isotype||Mouse / IgG1|
|Immunogen||Crude extract of splenic cells from a nude mouse engrafted with MCF-7 cells.|
|Storage buffer||tissue culture supernatant|
|Storage Conditions||4° C, do not freeze|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||1:25-1:50|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Immunohistochemistry (IHC)||See 2 publications below|
MA1-26237 detects Cytokeratin from human samples.
MA1-26237 has been successfully used in immunohistochemistry (paraffin) procedures.
The MA1-26237 immunogen is crude extract of splenic cells from a nude mouse engrafted with MCF-7 cells.
This antibody reacts Cytokeratin 5, Cytokeratin 6, Cytokeratin 8, Cytokeratin 17 and Cytokeratin 19.
The protein encoded by this gene is a member of the keratin gene family. The type II cytokeratins consist of basic or neutral proteins which are arranged in pairs of heterotypic keratin chains coexpressed during differentiation of simple and stratified epithelial tissues. This type II cytokeratin is specifically expressed in the spinous and granular layers of the epidermis with family member KRT10 and mutations in these genes have been associated with bullous congenital ichthyosiform erythroderma. The type II cytokeratins are clustered in a region of chromosome 12q12-q13.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Primary kaposiform hemangioendothelioma of a long bone: two cases in unusual locations with long-term follow up.
MA1-26237 was used in immunohistochemistry to report on two cases of primary kaposiform hemangioendothelioma of a long bone
|Ma J,Shi QL,Jiang SJ,Zhou HB,Zhou XJ||Pathology international (61:382)||2011|
Delineation of chondroid lipoma: an immunohistochemical and molecular biological analysis.
MA1-26237 was used in immunohistochemistry to study the immunohistochemistry and molecular biology of chondroid lipoma
|de Vreeze RS,van Coevorden F,Boerrigter L,Nederlof PM,Haas RL,Bras J,Rosenwald A,Mentzel T,de Jong D||Sarcoma (2011:null)||2011|
40-kDa keratin intermediate filament; 58 kda cytokeratin; CK-19; CK-5; cytokeratin 19; cytokeratin 6A; cytokeratin 6C; cytokeratin 6D; cytokeratin-17; cytokeratin-19; cytokeratin-5; cytokeratin-6C; cytokeratin-6E; cytokeratin-8; EHK; EHK1; epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types; EPPK; K1; kamp-keratin derived antimicrobial peptide; KDAMP; keratin 17, type I; keratin 19, type I; keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types); keratin 5, type II; keratin 6A, , type II; keratin 6A, type II; keratin 8, type II; keratin K6h; keratin, epidermal type II, K6A; keratin, type I, 40-kd; keratin, type II cytoskeletal 6A; keratin-17; keratin-19; keratin-6C; KRT1A; NEPPK; type-II keratin Kb12; type-II keratin Kb5; type-II keratin Kb6; type-II keratin Kb8
39.1; CARD2; CK-17; CK-6C; CK-6E; CK-8; CK19; CK5; CK6A; CK6C; CK6D; CK8; CYK8; DDD; DDD1; EBS2; K17; K19; K1CS; K2C8; K5; K6A; K6C; K6D; K8; KO; KRT17; KRT19; KRT5; KRT5A; KRT6A; KRT6C; KRT6D; KRT8; PC; PC2; PC3; PCHC1